Loading...
Loading...
India's sodium imports from CANADA total $145.6K across 182 shipments from 15 foreign suppliers. CELLBIOASIS INC leads with $51.8K in import value; the top 5 suppliers together control 63.6% of this origin. Leading Indian buyers include LUPIN LIMITED. This corridor reflects India's pharmaceutical import demand for sodium — a diversified sourcing base with multiple active suppliers from CANADA.

CELLBIOASIS INC is the leading Sodium supplier from CANADA to India, with import value of $51.8K across 11 shipments. The top 5 suppliers — CELLBIOASIS INC, FRESENIUS KABI CANADA LTD,, FRESENIUS KABI CANADA LTD, JAMP PHARMA CORPORATION, GLOBYZ PHARMA — collectively account for 63.6% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CELLBIOASIS INC | $51.8K | 11 | 35.6% |
| 2 | FRESENIUS KABI CANADA LTD, | $14.9K | 12 | 10.3% |
| 3 | FRESENIUS KABI CANADA LTD | $10.6K | 9 | 7.3% |
| 4 | JAMP PHARMA CORPORATION | $8.5K | 19 | 5.9% |
| 5 | GLOBYZ PHARMA | $6.6K | 31 | 4.5% |
| 6 | ACCORD HEALTHCARE INC | $5.4K | 14 | 3.7% |
| 7 | M/S AURO PHARMA INC.,CANADA | $5.1K | 1 | 3.5% |
| 8 | NEW LIFE MEDICALS (USA) INC | $4.5K | 4 | 3.1% |
| 9 | M/S TARO PHARMACEUTICALS INC | $3.9K | 2 | 2.7% |
| 10 | M/S. DELUXE HEALTH GROUP INC. | $3.8K | 1 | 2.6% |
| 11 | AURO PHARMA INC., CANADA | $3.7K | 9 | 2.6% |
| 12 | NEW LIFE MEDICALS (USA) INC. | $3.0K | 2 | 2.0% |
| 13 | MARCAN PHARMACEUTICALS INC | $2.8K | 1 | 2.0% |
| 14 | M/S. TARO PHARMACEUTICALS INC.. | $2.5K | 1 | 1.7% |
| 15 | TARO PHARMACEUTICALS INC | $2.1K | 2 | 1.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED | $40.6K | 18 | 27.9% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED | $25.4K | 18 | 17.4% |
| 3 | LUPIN LTD | $13.8K | 3 | 9.5% |
| 4 | INTAS PHARMACEUTICALS LIMITED | $9.8K | 18 | 6.8% |
| 5 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $9.1K | 39 | 6.2% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $8.5K | 6 | 5.9% |
| 7 | WINDLAS BIOTECH LIMITED | $5.2K | 2 | 3.5% |
| 8 | EUGIA PHARMA SPECIALITIES LIMITED | $5.1K | 1 | 3.5% |
| 9 | AUROBINDO PHARMA LTD | $4.4K | 10 | 3.1% |
| 10 | NATCO PHARMA LIMITED | $3.8K | 1 | 2.6% |
| 11 | XYLOPIA LABS PRIVATE LIMITED | $3.0K | 2 | 2.0% |
| 12 | EMCURE PHARMACEUTICALS LIMITED | $2.8K | 1 | 2.0% |
| 13 | CLIANTHA RESEARCH LIMITED | $2.0K | 4 | 1.4% |
| 14 | CHROMATO SCIENTIFIC PRIVATE LIMITED | $1.8K | 1 | 1.2% |
| 15 | BIOLOGICAL E. LIMITED | $1.4K | 13 | 1.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Sodium suppliers from CANADA to India include CELLBIOASIS INC, FRESENIUS KABI CANADA LTD,, FRESENIUS KABI CANADA LTD. The leading supplier is CELLBIOASIS INC with import value of $51.8K USD across 11 shipments. India imported Sodium worth $145.6K USD from CANADA in total across 182 shipments.
India imported Sodium worth $145.6K USD from CANADA across 182 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Sodium sourced from CANADA include LUPIN LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, LUPIN LTD. The largest buyer is LUPIN LIMITED with $40.6K in imports across 18 shipments.
The total value of Sodium imports from CANADA to India is $145.6K USD, across 182 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
182 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists